New Ray Medicine International Holding Limited 新銳醫藥國際控股有限公司

Pay for financial year ended 2014-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

HKD '000

Directors

1 Dai, Haidong 戴海東 CEO, Co-Fdr 10 557 49 616
2 Ho, Hau Cheung 何厚祥 INED 72 72
3 Lee, Chik Yuet 李植悅 ED 120 6 126
4 Leung, Eddie Chi Kin 梁志堅 INED 72 72
5 Sung, Andy Hak Keung 宋克强 INED 72 72
6 Yang, Fang (1976) 楊芳 ED 10 418 49 477
7 Zhou, Ling (1977) 周凌 Ch, Co-Fdr 10 704 49 763
Total 366 1,679 0 153 0 2,198

Main board pay history

Click on the year-end to see the pay details.

HKD'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 2,685 355 0 43 0 3,083 Report
2023-12-31 2,670 369 0 41 0 3,080 Report
2022-12-31 2,400 222 0 21 2,410 5,053 Report
2021-12-31 2,683 220 0 20 0 2,923 Report
2020-12-31 3,240 174 0 11 0 3,425 Report
2019-12-31 1,800 1,098 0 16 0 2,914 Report
2018-12-31 917 5,018 0 60 0 5,995 Report
2017-12-31 315 9,659 0 105 0 10,079 Report
2016-12-31 356 8,687 0 110 1,137 10,290 Report
2015-12-31 366 4,529 0 146 0 5,041 Report
2014-12-31 366 1,679 0 153 0 2,198 Report
2013-12-31 56 817 0 91 0 964 Report
Total 17,854 32,827 0 817 3,547 55,045

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top